Recherche
-
Severe phenotype in patients with large deletions of NF1
(Cancers. vol. 13, n° 12, 2021-06-13)Article de revueLibre accès -
Cannabis and exercise: Effects of Δ9-tetrahydrocannabinol on preference and motivation for wheel-running in mice
(Progress in Neuro-Psychopharmacology & Biological Psychiatry. vol. 105, 2021-03-08)Article de revueLibre accès -
The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis
(Respiratory Research. vol. 23, n° 1, pp. 214, 2022-08-23)Article de revueLibre accès -
Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase((R)))
(Antibiotics. vol. 12, n° 5, 2023-04-25)Article de revueLibre accès -
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France
(Drug Safety. vol. 46, n° 12, pp. 1381-1389, 2023-12-01)Article de revue -
Brain imaging determinants of functional prognosis after severe endocarditis: a multicenter observational study
(Neurological Sciences. vol. 43, n° 6, pp. 3759-3768, 2022-06)Article de revueLibre accès -
First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective
(Cancers. vol. 13, n° 23, 2021-12-05)Article de revueLibre accès -
High prevalence of spin was found in pharmacovigilance studies usingdisproportionality analyses todetectsafetysignals: a meta-epidemiologicalstudy: Spin in pharmacovigilance disproportionality analyses
(Journal of Clinical Epidemiology. vol. 138, pp. 73-79, 2021-06-26)Article de revue -
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Antipsychotics and risk of QT prolongation: a pharmacovigilance study
(Psychopharmacology. vol. 240, pp. 199-202, 2022-12-14)Article de revue